Acura Pharmaceuticals, Inc. · Palatine, IL United States ·(NASDAQ (CM): ACUR)

Acura Pharmaceuticals is working to make it harder to abuse otherwise good drugs. The company has developed a technology to add abuse-deterring agents to commonly abused pharmaceuticals. If a drug with these agents (what Acura calls Aversion Technology) is taken in excess, the ingredients cause unpleasant symptoms shortly after ingestion. If a tablet is crushed and inhaled other ingredients will cause nasal irritation; and if an abuser attempts to dissolve the powder, it will form a non-injectable gel. Lead product candidate Acurox combines Aversion Technology with the commonly abused opioid painkiller oxycodone HCl.  To read the full description, subscribe now.